N-Acetyl Selank vs Selank
A neutral, side-by-side comparison of two nootropic & cognitive peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
N-Acetyl Selank
Acetylated variant of Selank with enhanced stability and bioavailability. The N-acetyl modification protects the peptide from rapid enzymatic degradation, extending its active half-life relative to standard Selank. Provides anxiolytic, nootropic, and immunomodulatory effects comparable to or exceeding standard Selank with potentially greater duration from each dose.
Full profileSelank
Selank is a synthetic heptapeptide derived from tuftsin, an endogenous immunomodulatory peptide. Developed in Russia by the Institute of Molecular Genetics, it has been studied extensively for anxiolytic, nootropic, and immunomodulatory effects. It is registered as a medication in Russia and Ukraine.
Full profile| N-Acetyl Selank | Selank | |
|---|---|---|
| Category | Nootropic & Cognitive | Nootropic & Cognitive |
| Also known as | Selank-A, N-Ac-Selank, acetylated selank, N-acetyl selank | TP-7, Tuftsin analog |
| Evidence | Research-stage | Research-stage |
| Dosing range | 100mcg–500mcg mcg, 1–2x daily intranasal | 250mcg–1000mcg mcg, 1–2x daily |
| Administration | Intranasal spray, Subcutaneous injection | Intranasal (most common — direct CNS delivery), Subcutaneous injection |
| Key side effects | Mild sedation (acute), Fatigue, Headache (rare), Nasal irritation (intranasal route) | Mild sedation at high doses, Nasal irritation (intranasal route), Generally very well-tolerated, No reported dependence or withdrawal |
| Cited sources | 2 references | 1 reference |
Key differences
- Administration: N-Acetyl Selank — Intranasal spray, Subcutaneous injection; Selank — Intranasal (most common — direct CNS delivery), Subcutaneous injection.
- Frequency: N-Acetyl Selank is typically 1–2x daily intranasal; Selank is 1–2x daily.
- Research depth: this profile cites 2 sources for N-Acetyl Selank vs 1 for Selank.
How each works
N-Acetyl Selank
N-Acetyl Selank shares Selank's core mechanism — BDNF/NGF upregulation, enkephalinase inhibition, and GABA-A receptor complex modulation — with improved metabolic stability from the N-terminal acetyl group. The acetyl modification protects against aminopeptidase N and angiotensin-converting enzyme cleavage, extending the peptide's active residence time in neural tissue after intranasal administration.
Selank
Selank modulates GABA-A receptors and influences BDNF expression, producing anxiolytic effects comparable to benzodiazepines without sedation or dependence. Russian clinical studies report improvements in generalized anxiety disorder, cognitive performance, and mood stability. It also appears to modulate T-helper cell ratios and interferon production.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.